Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Daniel Muñoz-Espín"'
Autor:
Hui‐Ling Ou, Reuben Hoffmann, Cristina González‐López, Gary J. Doherty, James E. Korkola, Daniel Muñoz‐Espín
Publikováno v:
Molecular Oncology, Vol 15, Iss 10, Pp 2634-2671 (2021)
Senescence refers to a cellular state featuring a stable cell‐cycle arrest triggered in response to stress. This response also involves other distinct morphological and intracellular changes including alterations in gene expression and epigenetic m
Externí odkaz:
https://doaj.org/article/f762a6bb0f37468c999497ca19af1f9b
Publikováno v:
EMBO Molecular Medicine, Vol 11, Iss 12, Pp 1-19 (2019)
Abstract Organismal ageing is a complex process driving progressive impairment of functionality and regenerative potential of tissues. Cellular senescence is a state of stable cell cycle arrest occurring in response to damage and stress and is consid
Externí odkaz:
https://doaj.org/article/f1552ee743934e8493ca70abe9e11fb1
Autor:
Daniel Muñoz-Espín
Publikováno v:
Translational Medicine of Aging, Vol 3, Iss , Pp 1-5 (2019)
Ageing and multiple chronic diseases in humans associate with an aberrant accumulation of senescent cells in a diversity of tissues, which contributes to organ dysfunction and drives their pathological manifestations. It emerges that elimination of s
Externí odkaz:
https://doaj.org/article/60963e2fd06743e0b6f8c22ca2339444
Autor:
Daniel Muñoz‐Espín, Miguel Rovira, Irene Galiana, Cristina Giménez, Beatriz Lozano‐Torres, Marta Paez‐Ribes, Susana Llanos, Selim Chaib, Maribel Muñoz‐Martín, Alvaro C Ucero, Guillermo Garaulet, Francisca Mulero, Stephen G Dann, Todd VanArsdale, David J Shields, Andrea Bernardos, José Ramón Murguía, Ramón Martínez‐Máñez, Manuel Serrano
Publikováno v:
EMBO Molecular Medicine, Vol 10, Iss 9, Pp 1-18 (2018)
Abstract Senescent cells accumulate in multiple aging‐associated diseases, and eliminating these cells has recently emerged as a promising therapeutic approach. Here, we take advantage of the high lysosomal β‐galactosidase activity of senescent
Externí odkaz:
https://doaj.org/article/d67df62499c14123a2c81e830cc433e4
Autor:
Jose M. Bermúdez-Muñoz, Adelaida M. Celaya, Ángela García-Mato, Daniel Muñoz-Espín, Lourdes Rodríguez-de la Rosa, Manuel Serrano, Isabel Varela-Nieto
Publikováno v:
Antioxidants, Vol 10, Iss 9, p 1351 (2021)
Stress-activated protein kinases (SAPK) are associated with sensorineural hearing loss (SNHL) of multiple etiologies. Their activity is tightly regulated by dual-specificity phosphatase 1 (DUSP1), whose loss of function leads to sustained SAPK activa
Externí odkaz:
https://doaj.org/article/748624f927dc4e19a79baea627396416
Autor:
Bruno de Paula, Rosalind Kieran, Samantha Shui Yuan Koh, Susanne Crocamo, Eliana Abdelhay, Daniel Muñoz-Espín
Publikováno v:
Molecular Cancer Therapeutics. 22:583-598
Triple-negative breast cancer (TNBC) is associated with an elevated risk of recurrence and poor prognosis. Historically, only chemotherapy was available as systemic treatment, but immunotherapy and targeted therapies currently offer prolonged benefit
Autor:
Daniel Muñoz-Espín, Eliana Abdelhay, Susanne Crocamo, Samantha Shui Yuan Koh, Rosalind Kieran, Bruno de Paula
Examples of “one-two punch” strategy in TNBC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5aa291a46123a1684864d041f0bd258
https://doi.org/10.1158/1535-7163.22758707.v1
https://doi.org/10.1158/1535-7163.22758707.v1
Autor:
Daniel Muñoz-Espín, Eliana Abdelhay, Susanne Crocamo, Samantha Shui Yuan Koh, Rosalind Kieran, Bruno de Paula
Examples of senolytics clinical performance in solid tumors and breast cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::249e413f0238ed40bd6491126e6a5d6e
https://doi.org/10.1158/1535-7163.22758704
https://doi.org/10.1158/1535-7163.22758704
Autor:
Daniel Muñoz-Espín, Eliana Abdelhay, Susanne Crocamo, Samantha Shui Yuan Koh, Rosalind Kieran, Bruno de Paula
Examples of senescence inducers in TNBC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc295028973e66da381da952ccbd6f3
https://doi.org/10.1158/1535-7163.22758710.v1
https://doi.org/10.1158/1535-7163.22758710.v1
Autor:
Daniel Muñoz-Espín, Eliana Abdelhay, Susanne Crocamo, Samantha Shui Yuan Koh, Rosalind Kieran, Bruno de Paula
Triple-negative breast cancer (TNBC) is associated with an elevated risk of recurrence and poor prognosis. Historically, only chemotherapy was available as systemic treatment, but immunotherapy and targeted therapies currently offer prolonged benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0791f8c492c4a7929a31eed0a86223cb
https://doi.org/10.1158/1535-7163.c.6597340.v1
https://doi.org/10.1158/1535-7163.c.6597340.v1